Navigation Links
Plenary speakers address challenges in the delivery of sustained antiretroviral therapy in developing countries, call for social scientists to take their place at the HIV/AIDS policy-making table, and stress the need for a long-term response to AIDS
Date:7/19/2011

ical. Kippax argued that there is a need for social scientists to be at the table when it comes to discussing what many experts currently consider to be the greatest challenge to HIV/AIDS policy making - prevention.

Irrespective of whether prevention programmes or interventions advocate the use of condoms, clean needles and syringes, microbicides, pre- or post-exposure prophylaxis, or treatment as prevention - all prevention requires that people change their social practices: changes which cannot be effectively sustained unless they are supported by broader social transformation.

Challenges of Antiretroviral Therapy (ART) in Developing Countries

Serge Eholi (Ivory Coast) Professor of Tropical and Infectious Diseases at the Medical School of the University of Abidjan, focused on the challenges of sustaining antiretroviral therapy initiatives in developing countries.

A decade after the first antiretroviral therapy initiatives were initiated in developing countries, the number of HIV-infected individuals receiving ART has significantly increased. Recent data estimate that six million HIV-infected patients started ART and four and a half million of them (75 per cent) live in sub-Saharan Africa, and significant results have been obtained in decreasing mortality and morbidity.

Seven areas were identified as challenging in the ongoing delivery of ART in developing countries:

  • financing the sustainability of ART-programmes, particularly in the context of the current adverse economic climate and with insufficient contributions from national governments;
  • the high incidence of mortality and severe mortality during the first year following ART-initiation;
  • the adaptation of programmes, physicians, countries and partners to the WHO 2010 revised guidelines for adults and adolescents;
  • an increasing number of HIV-infected patients failing first-line treatment: the cost of second line treatment is
    '/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
International AIDS Society
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Plenary speech by HHMI professor highlights efforts of scientist-educators
2. Christopher Marley and James McWilliams to give plenary speeches at Entomology 2010
3. Plenary lecturers share science and policy perspectives
4. TERMIS-North America announces speakers for annual event
5. Excellence in Paediatrics conference line-up includes WHO and CDC pandemic speakers
6. Conference to address health and security implications of global water management
7. Network created to address obesity, chronic health issues in Appalachian region
8. UofL hosts address by Nobel Laureate, DNA structure co-discoverer James Watson
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. High-profile panel to address causes, consequences of the politicization of science
11. Historian says history of nuclear power needs to be addressed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... LAKE CITY , June 25, 2015  Imagine ... first steps toward a healthier, happier life. That,s exactly ... is designed to do. The cutting-edge, portable health program ... offers real-life solutions to help improve your lifestyle and ... Association awards dinner and gala Wednesday night, USANA,s THA ...
(Date:6/24/2015)... , June 24, 2015 This report provides ... the next six years. It contains an analysis of ... along with their impact from the short, medium, and ... discusses the industry, market, and technology trends that currently, ... need of concerned authorities to efficiently manage the increasing ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... Depending on the level of smoking and leisure time ... have no effect, on the risk of pneumonia, according to ... laboratory studies, vitamin E has influenced the immune system. In ... infections. However, the importance of vitamin E on human infections ...
... researchers at Cardiff University is opening up new possibilities for ... materials such as metal ions into cells, a process which ... One technique currently used is called the ,Trojan Horse, in ... naturally taken up by cells. The Cardiff team, ...
... In the U.S., even zoo gorillas need to switch to ... we believe like humans," said Elena Hoellein Less, a PhD candidate ... heart disease is the number one killer of male Western lowland ... After Brooks, a 21-year-old gorilla, died of heart failure ...
Cached Biology News:Sleeping Trojan horse to aid imaging of diseased cells 2Apes shed pounds while doubling calories, CWRU researcher finds 2Apes shed pounds while doubling calories, CWRU researcher finds 3
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
(Date:6/30/2015)... WA (PRWEB) , ... June 30, 2015 , ... ... a hydrophilic filter that does not sacrifice selectivity to achieve faster flow rates ... combines extremely fine pores with significant open space to allow easy liquid flow ...
Breaking Biology Technology:UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... St. Jude Medical will add up to 1,200 new, jobs within 36 ... ... Rico, ARECIBO, Puerto Rico, Sept. 19 St. Jude,Medical, Inc. (NYSE: ... Medical recently purchased a facility in Arecibo,s,Santana Industrial Park, which will allow the ...
... PARSIPPANY, N.J., Sept. 19 NPS,Pharmaceuticals, Inc. (Nasdaq: ... Food and,Drug Administration,s Office of Orphan Products Development ... [rDNA origin] for,injection) for the treatment of hypoparathyroidism, ... is no FDA-approved therapy. Hypoparathyroidism afflicts approximately ...
... Sept. 19 NeurogesX, Inc.,(Nasdaq: NGSX ), a ... today that it is scheduled to present,at the 2007 ... Anthony DiTonno, President and Chief Executive Officer, and Jeffery,Tobias, ... Tuesday, September 25, 2007 Time: ...
Cached Biology Technology:St. Jude Medical to Expand Puerto Rico Operations 2PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 2PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism 3NeurogesX to Present at UBS 2007 Global Life Sciences Conference 2NeurogesX to Present at UBS 2007 Global Life Sciences Conference 3
... an imaging based plate reader for ... throughput screening which can utilize both ... light sources and cameras in the ... in photon detection technology. It ...
... Experion StdSens reagents and supplies, for ... supplies sufficient to perform standard-sensitivity RNA ... on the Experion automated electrophoresis system. ... 20 microliters RNA StdSens stain, 20 ...
... 3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide White solid. PROTECT FROM ... cell-permeable sulfanamido-benzbromarone compound that acts as ... inhibitor of PTP1B (IC 50 ... for PTP1B 403 and PTP1B ...
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
Biology Products: